For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers said the test could improve early detection while reducing unnecessary follow-up procedures. Stockholm3 is still ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...

A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer. Instead of simply shrinking tumors, the experimental medicine appears to ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use Tempus AI, Inc., a leader in ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing forms is lacking.

Asymptomatic prostate-specific antigen (PSA) testing in primary care was associated with a lower risk for mortality due to prostate cancer than no testing. Researchers conducted a nested case-control ...